Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Long-acting injectable formulations and crystalline forms of buprenorphine derivatives

Long-acting injectable formulations and crystalline forms of buprenorphine derivatives

US Patent 11524965 · Granted Dec 13, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Naltrexone injectable sustained release formulation2025
Naltrexone injectable sustained release formulation2025
Ketamine pamoate and use thereof2024
Ketamine pamoate and use thereof2024
Sustained-release buprenorphine formulations2020
Sustained-release buprenorphine formulations2020
Sustained-release buprenorphine formulations2020
Compositions and methods for increasing telomerase activity2018
Compositions and methods for increasing telomerase activity2016
Compositions and methods for increasing telomerase activity2013